Evidence mapPaperPMID 39746549Full record

ReviewDiabetes research and clinical practice2025

Managing obesity in adults with type 1 diabetes.

Alejandro Campos, Rene Rivera Gutierrez, Rodolfo J Galindo, Rozalina G McCoy, Maria D Hurtado Andrade

Abstract readReview
In one paragraph

Review in Diabetes research and clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Obesity in Adults with Type 1 Diabetes Mellitus.Journal of obesity & metabolic syndrome · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alejandro CamposPrecision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1(st) St SW, Rochester, MN 55905, USA. Electronic address: angel.CamposRodriguez@bmc.org.
Rene Rivera GutierrezPrecision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1(st) St SW, Rochester, MN 55905, USA; Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA. Electronic address: rivera.rene@mayo.edu.
Rodolfo J GalindoDivision of Endocrinology, University of Miami, 1450 Northwest 10(th) Avenue, Miami, FL 33136, USA. Electronic address: rodolfo.galindo@miami.edu.
Rozalina G McCoyDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, 670 West Baltimore Street, Baltimore, MD 20852, USA; University of Maryland Institute for Health Computing, 6116 Executive Blvd, Bethesda, MD 20852, USA. Electronic address: rozalina.mcmoy@som.umaryland.edu.
Maria D Hurtado AndradePrecision Medicine for Obesity Program, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1(st) St SW, Rochester, MN 55905, USA; Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA. Electronic address: hurtado.mariadaniela@mayo.edu.

Funding

Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease(ESRD) Patients with Type 2 DiabetesK23DK123384 · NIDDK · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Rodolfo Galindo · 2022 to 2024
$369k
NIAMS NIH HHS K12 AR084222NIDDK NIH HHS K23 DK114497NIDDK NIH HHS K23 DK123384
6 · The paper itself

Abstract

As the prevalence of obesity has reached epidemic proportions, its prevalence has also increased among adults living with type 1 diabetes mellitus. Unlike the pathophysiologic relationship between obesity and type 2 diabetes mellitus, the relationship between obesity and type 1 diabetes mellitus, and management of obesity in the setting of type 1 diabetes mellitus, have not been well reviewed. In this article, we discuss the comprehensive management of obesity in adults with type 1 diabetes mellitus, focusing on medical nutrition therapy and adjunct therapies such as weight loss-promoting medications and metabolic/bariatric surgery.

Indexed as

Diabetes Mellitus, Type 1ObesityAdultAnti-Obesity AgentsBariatric SurgeryHumansWeight LossAnti-Obesity AgentsAntiobesity MedicationsBariatric SurgeryInsulin Dose AdjustmentLifestyle InterventionsObesityType 1 Diabetes

Identifiers

PMID39746549
PMCPMC11788068

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.